Therapeutic Effect of a Poly(ADP-Ribose) Polymerase-1 Inhibitor on Experimental Arthritis by Downregulating Inflammation and Th1 Response

Elena Gonzalez-Rey, Ruben Martínez-Romero, Francisco O'Valle et al. · 2007

Read Therapeutic Effect of a Poly(ADP-Ribose) Polymerase-1 Inhibitor on Experimental Arthritis by Downregulating Inflammation and Th1 Response by Elena Gonzalez-Rey, Ruben Martínez-Romero, Francisco O'Valle et al. (2007) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0001071.txt.

Description

Elena Gonzalez-Rey, Ruben Martinez-Romero, Francisco O'Valle and colleagues tested a DNA repair enzyme blocker against arthritis, in PLOS ONE in 2007. PARP-1 is an enzyme that helps repair DNA and keep the genome intact. It also drives inflammation forward, and blocking it has eased inflammatory responses in other settings.

The team report a therapeutic effect of a PARP-1 inhibitor on experimental arthritis, by downregulating inflammation and the Th1 immune response. One target touching both joint inflammation and the immune pattern behind it is attractive. Arthritis drugs often trade benefit for broad immune suppression, so any narrower route deserves the test this paper gives.

Catalog record

CREATORElena Gonzalez-Rey, Ruben Martínez-Romero, Francisco O'Valle et al.
YEAR2007
COLLECTIONPAPERS
FORMATTXT
FILE SIZE29 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0001071

Browse the full library · About the Tower of Babel